Syphilis diagnosis is based on clinical observation, serological analysis, and dark-field microscopy (DFM) detection of Treponema pallidum subsp. pallidum, the etiological agent of syphilis, in skin ulcers. We performed a nested PCR (nPCR) assay specifically amplifying the tpp47 gene of T. pallidum from swab and blood specimens. We studied a cohort of 294 patients with suspected syphilis and 35 healthy volunteers. Eighty-seven of the 294 patients had primary syphilis, 103 had secondary syphilis, 40 had latent syphilis, and 64 were found not to have syphilis. The T. pallidum nPCR results for swab specimens were highly concordant with syphilis diagnosis, with a sensitivity of 82% and a specificity of 95%. Reasonable agreement was observed between the results obtained with the nPCR and DFM methods (kappa ‫؍‬ 0.53). No agreement was found between the nPCR detection of T. pallidum in blood and the diagnosis of syphilis, with sensitivities of 29, 18, 14.7, and 24% and specificities of 96, 92, 93, and 97% for peripheral blood mononuclear cell (PBMC), plasma, serum, and whole-blood fractions, respectively. HIV status did not affect the frequency of T. pallidum detection in any of the specimens tested. Swab specimens from mucosal or skin lesions seemed to be more useful than blood for the efficient detection of the T. pallidum genome and, thus, for the diagnosis of syphilis.
S
yphilis is a multistage disease caused by the spirochete Treponema pallidum subsp. pallidum. Syphilis of less than 1 year's duration is classified as early syphilis, whereas disease of longer duration is defined as late syphilis (4) . Early syphilis is comprised of primary syphilis, which is clinically characterized by the presence of chancre, secondary syphilis, which is clinically polymorphous, and early latent syphilis of less than 1 year's duration. All other forms of syphilis are classified as late syphilis, whether clinical signs are present or not. T. pallidum can persist in the body and affect several organs. Multiple complications of syphilis may appear, including gumma, neurosyphilis, and cardiovascular syphilis. There has been an increase in the frequency of early syphilis in most Western countries since 2000 (7) , the affected population being characterized by a high proportion of men having sex with men (MSM) and the overrepresentation of HIV-infected patients (almost 50% in our experience) (11, 12) .
In situations in which the direct detection of T. pallidum is not possible, syphilis diagnosis is based on clinical and serological assays of two types: a treponemal test (T. pallidum particle agglutination assay [TPPA] or T. pallidum hemagglutination assay [TPHA] ) and a nontreponemal test (rapid plasmid reagin [RPR] or venereal disease research laboratory [VDRL] test). In France, the use of one test of each of the two types is mandatory for the serological diagnosis of syphilis in routine practice (8) . Despite the widespread use of these serological tests, they are subject to certain limitations. The VDRL test is not specific for T. pallidum, but it is highly sensitive for the detection of secondary syphilis. However, detection sensitivity may be as low as 70 to 80% for primary syphilis, particularly at early stages. Moreover, nontreponemal tests may result in false-positive detection, not only in cases of nonvenereal treponematosis (as for treponemal tests) but also in many other clinical situations, such as pregnancy, autoimmune diseases, and infections. Furthermore, a positive result in a treponemal or nontreponemal test may indicate past infection rather than active syphilis (25) .
T. pallidum cannot be cultured on synthetic media, and its detection is based on direct visualization by dark-field microscopy (DFM). However, DFM is highly operator dependent and cannot be used for blood or for oral chancres, as it can give false-positive results due to the presence of saprophytic spirochetes in the oral cavity. New detection strategies have been developed during the last 15 years that are based on advances in our knowledge of the sequence of the T. pallidum genome (13 (2, 3, 6, 15, 17, 18, 23, 30, 31, 32, 34, 39) , and others, such as polA, being involved in genome duplication (9, 27, 28, 35) . Recent comparisons of the results for the detection of T. pallidum DNA obtained by the amplification of the tpp47, bmp, polA, and 23S rRNA genes showed that these tests give concordant results (29) .
PCR techniques detect T. pallidum DNA with various prevalences in different types of specimens, including swabs from chancres and skin biopsy specimens from patients with secondary syphilis (1, 24, 39) . T. pallidum DNA also can be detected in skeletal bones and various body fluids, including serum (2), cerebrospinal fluid, and urine (5, 14, 16, 18, 37) . T. pallidum DNA also has been detected in specimens from placenta (15) , gastric lesions (22) , and neurons (21) .
The aim of this study was to evaluate an nPCR assay for detecting T. pallidum DNA and to investigate its clinical value for the diagnosis of syphilis in a large prospective cohort of patients consulting at two sexually transmitted disease (STD) centers. We compared the results of our in-house nPCR assay to serological tests and DFM findings, when available.
MATERIALS AND METHODS
Patients. All patients with suspected syphilis visiting two STD centers in Paris between May 2005 and November 2009 were asked to participate in this prospective study. Patients giving informed consent for participation were enrolled in the study. A group of 35 healthy volunteers testing negative for syphilis in serological tests and with no symptoms or signs of active syphilis served as the control for experiments on blood.
Diagnosis of syphilis. The diagnosis of clinically active early syphilis (primary or secondary) was based on CDC criteria (4). All patients classified as having probable or confirmed syphilis were considered to have syphilis for the purposes of this study. Primary syphilis was confirmed if the patient presented one or more chancres and T. pallidum was detected by DFM. The diagnosis was considered probable if the patient presented one or more chancres or ulcers consistent with the diagnosis of primary syphilis and a positive result was obtained in a serological test (see below). Secondary syphilis was confirmed in patients presenting cutaneous and/or mucosal lesions, either localized or dispersed over the body and with or without regional lymphadenopathy, in whom T. pallidum was detected directly by DFM. The diagnosis of secondary syphilis was considered probable for patients presenting the clinical criteria described above for whom positive results were obtained in nontreponemal and treponemal serological tests. Patients with no symptoms who had had an initial infection in the previous 12 months were classified as having early latent syphilis if they fulfilled at least one of the following criteria: (i) documented seroconversion or an increase in titer by a factor of at least four in a nontreponemal test in the last 12 months; (ii) a history of symptoms consistent with primary or secondary syphilis during the previous 12 months; (iii) a history of exposure through sexual relations with a partner with confirmed or probable primary or secondary syphilis or probable early latent syphilis (documented independently as being of less than 1 year's duration); and (iv) positive reaction in nontreponemal and treponemal tests for an individual whose only possible exposure occurred within the preceding 12 months. All patients who could not be classified according to this case definition were considered not to have syphilis and were included as controls in subsequent blind studies.
Sample processing. For patients with mucosal ulceration or erosion, the lesion exudate was collected with a swab. In cases of secondary syphilis in which the patients had no mucosal lesions but did have skin lesions, such as macules or papules, we scraped the lesions gently to obtain a serous exudate, which was collected on a swab. For DFM analysis, the lesion exudate was collected with a bacteriology loop and transferred immediately to a glass slide for examination. For DNA extraction, lesion exudate was collected with a swab, which was then immediately placed in 1 ml of sterile phosphate-buffered saline (PBS). Blood collected in a dry tube (20 ml) was centrifuged for 10 min at 2,500 ϫ g at room temperature, and the supernatant corresponding to the serum was collected. Blood collected in EDTA tubes (10 ml) was centrifuged for 30 min on a Ficoll Hypaque layer at 2,500 ϫ g at room temperature. All samples were stored at Ϫ20°C until nPCR was performed.
Serological tests. Serum samples from all patients included in this study were routinely analyzed with the VDRL test (Latex Pasteur, BioRad, France) and the TPHA test (Newmarket, United Kingdom) according to the manufacturers' instructions. We checked for the presence of HIV-1 and HIV-2 antigens and antibodies in the serum in a routine automated enzyme-linked immunosorbent assay (ELISA) (Genscreen ULTRA HIV Ag-Ab; Bio-Rad, Marne-la-Coquette, France) that was carried out according to the manufacturer's instructions. The detection of antibodies was confirmed by immunoblotting for HIV-1 and HIV-2 (NEW Lav-Blot I and New Lav-Blot II; Bio-Rad, Marne-la Coquette, France).
DNA extraction. DNA was extracted from swab exudate and from PBMC, plasma, serum, and whole blood with the Nucleospin blood kit (Macherey-Nagel Eurl, Hoerd, France), which was used according to the manufacturer's instructions. Briefly, we combined 200 l of sample with an equal volume of lysis buffer containing guanidine hydrochloride, Tween 20, and 1.4 mg/ml proteinase K. This mixture was incubated for 30 min at 70°C for cell lysis. All DNA samples were stored at 4°C for no more than 2 days before testing, thus avoiding the need for repeated freeze/thaw cycles. DNA samples were stored at Ϫ20°C.
Dark-field microscopy. Dark-field microscopy, at ϫ900 magnification, was carried out for the direct detection of spirochetes in swab samples. The detection of at least one typical motile organism by two independent experienced observers constituted a positive result.
nPCR method. The nPCR assay for the detection of T. pallidum DNA was based on the amplification of the target gene tpp47. The oligonucleotide primers Tpe, Tps, KO5, and KO3B were synthesized and purified by MGV-Biotech (Courtaboeuf, France). The sequences were the following: Tps, 5=-TTCGATGCAGTTTCTCGCGCCAACC-3=; Tpe, 5=-CTACTGG GCCACTACCTTCGCACG-3=; KO5, 5=-CCCGTTCGCAATCAAAGTC AGCCT-3=; and KO3B, 5=-GACGCGAGCTACACCAATCTGATG-3=. All PCRs were performed in a GeneAmp PCR system 9700 (Applied Biosystems, Foster City, CA). PCR assays were carried out in a final volume of 25 l containing 2 l of extracted template DNA. For the first PCR (PCR 1), which amplified a 1,103-bp fragment, each reaction mixture contained 2.5 l of 10ϫ PCR buffer (500 mM KCl, 200 mM Tris-HCl [pH 8.4]), 1.5 l of 50 mM MgCl 2 (giving a final concentration of 3 mM), 0.5 l of each primer (0.2 mM final concentration), 0.2 l (1 U) of native Taq DNA polymerase (Invitrogen, Carlsbad, CA), and distilled water. For the second PCR (PCR 2), which amplified a 168-bp fragment, 3 l of the products of PCR 1 was used as the template and the MgCl 2 concentration was decreased to 1 mM. The PCR conditions for tpp47 amplification were the following: 94°C for 3 min, followed by 20 cycles (for PCR 1) and 35 cycles (for PCR 2) of 94°C for 1 min, 68°C for 30 s, and 72°C for 2 min, with a final extension at 72°C for 10 min. The nPCR products were analyzed by electrophoresis in a 1.7% agarose gel, and the amplified nucleotide bands were visualized by the UV transillumination of the ethidium bromidestained gel, with a 50-bp DNA ladder (Invitrogen, Carlsbad, CA) used as a molecular size marker. DNA extraction, nPCR, and electrophoresis were carried out in three different rooms to prevent contamination. Control assays were run in parallel and consisted of a positive control prepared from the testis of a rabbit inoculated with T. pallidum (Nichols strain) and a no-template negative control (water). Before the analysis of clinical specimens, the analytical sensitivity of the test was determined with a suspension of T. pallidum strain Nichols containing 4 ϫ 10 7 organisms/ml (kindly provided by the Institut Alfred Fournier, Paris, France), which was subjected to 10-fold serial dilution in phosphate-buffered saline, plasma, PBMC, serum, and whole blood from a negative-control patient. DNA was extracted as described above. The detection limit of this nPCR assay was estimated at 20 organisms/ml. We assessed the specificity of the amplification reaction by purifying the amplified PCR fragment by filtration through a Microcon YM-100 (Millipore) filtration membrane and carrying out the amplification on a Thermocycler GenAmp PCR system 9700 set to run 25 cycles of 96°C for 10 s, 50°C for 10 s, and 60°C for 4 min in the presence of the KO3B and KO5 probes mixed with BigDye reagent. Amplified products were then separated by high-resolution electrophoresis in a polyacrylamide gel run on an ABI 3100 genetic analyzer system (Applied Biosystems). The results were analyzed with Sequence Navigator software (data not shown). The amplification process and subsequent analysis were performed in a dedicated laboratory for PCR amplification physically separate from the sample preparation area to prevent contamination.
Statistical analysis.
We assessed the concordance between the clinical diagnosis of syphilis and T. pallidum nested PCR results by determining the sensitivity (Se), specificity (Sp), positive predictive value (PPV), negative predictive value (NPV), Youden's index, likelihood positive and negative ratios (LR ϩ and LR Ϫ ), and kappa value (). Fisher's exact test was used to compare differences in proportions, with values of P Յ 0.05 considered significant.
Real-time PCR for HSV-1 and HSV-2. Superficial genital swabs were discharged into 200 l of sterile saline, and DNA was extracted with the QIAmp blood DNA extraction kit (Qiagen). HSV DNA was detected and genotyped by real-time PCR with the primers HSVF (5=-T TTGTGTACATGTCCCCGTTTTAC-3=) and HSVR (5=-AGGTCGCGC GCGTAGAAG-3=), which amplified a 93-bp fragment of the glycoprotein B (gB) gene of the HSV genome. We used two probes, HSV1P (5=-FAM-CACACCGAACACACCA-MGB-3=) and HSV2P (5=-FAM-CACACCAC CGAGCACACCA-MGB-3=), for the specific detection of herpes simplex viruses 1 (HSV-1) and HSV-2, respectively.
RESULTS
Based on laboratory findings and clinical evaluation, 230 of the 294 patients with suspected syphilis were considered to have syphilis, with the remaining 64, including 5 patients with dubious DFM findings and negative results in serological tests during a 1-month period, considered not to have syphilis. Twenty-two of the 64 patients without syphilis had herpes simplex infection, and the other 42 patients presented aphthous ulceration, pigmented fixed eruption, caustic ulcerations, lymphogranuloma venereum (LGV), chancroid, traumatic ulcerations (n ϭ 12), or ulcerations of unknown origin (n ϭ 30). Most (96%) of the 294 patients studied were male and aged between 37 and 47 years. Most were MSM (66%), and 38% were infected with HIV. Based on the CDC criteria, 87 patients (29%) presented primary syphilis, 103 patients (35%) had clinical signs of secondary syphilis, and early latent syphilis was diagnosed in 40 patients (14%) ( Table 1) .
Comparison of DFM and nPCR assays. We compared the detection of T. pallidum in swabs by the DFM and nPCR methods. We analyzed the results for 152 patients, 65 of whom presented primary syphilis, 44 of whom had secondary syphilis, and 43 of whom did not have syphilis. The patients without syphilis were further subdivided into HSV-infected patients (n ϭ 12) and patients presenting other types of ulceration unrelated to syphilis (n ϭ 31). DFM and nPCR resulted in the diagnosis of syphilis in 80 and 90, respectively, of the 109 patients with syphilis (Table 2 ). For DFM, overall sensitivity was 73% and specificity was 88%. Youden's index was 0.62, the PPV was 94%, and the NPV was 56%, indicating good agreement between DFM results and syphilis diagnosis. For nPCR, overall sensitivity was 82% and specificity was 95%. Youden's index was 0.78, the PPV was 94%, and the NPV was 57%, indicating strong agreement between nPCR results and syphilis diagnosis. Moreover, the likelihood positive ratio (LR ϩ ) was 18 and the likelihood negative ratio (LR Ϫ ) was 0.18, indicating that the confirmation of syphilis diagnosis by the analysis of swab samples was highly likely. The five patients classified as not having syphilis for whom DFM results were unclear did not give positive results in the nPCR. In contrast, two patients classified as not having syphilis gave positive results in the nPCR but not on DFM. This difference between DFM and nPCR results was not statistically significant when differences in detection sensitivity as a function of sampling site were taken into account. The nPCR described here gave significantly better results for T. pallidum detection than DFM in cases of primary syphilis (P ϭ 0.011) but not in cases of secondary syphilis (P ϭ 0.339). Overall, 85 of the 152 specimens tested positive by DFM and 92 tested positive by nPCR, giving a concordance rate of 77% ( ϭ 0.53) between the two tests ( Table 2) . Evaluation of T. pallidum nPCR for the detection of all-stage syphilis from blood samples. Blood samples were collected from 297 patients: 81 with primary syphilis, 97 with secondary syphilis, and 40 with latent syphilis. We also included 44 patients presenting ulcerations who were found not to have syphilis on serological testing, as well as 35 healthy volunteers (Table 3 ). Blood samples corresponding to the PBMC, plasma, serum, and whole-blood fractions were analyzed by nPCR targeting the tpp47 gene. The results of the nPCR were negative for all of the healthy volunteers. Seven of the 10 patients with ulcerations of unknown etiology tested positive by nPCR. We cannot exclude the possibility that these patients had early syphilis without clinical signs and with antibody levels too low for detection in serological tests. In patients with primary and secondary syphilis, the frequency of T. pallidum genome detection was low for the PBMC, plasma, serum, and whole-blood fractions, with sensitivities of 12 to 38%. Detection levels were very low in patients with latent syphilis, with sensitivities of 4 to 16% (Table 3 ). The specificity of T. pallidum genome detection was high (from 92 to 97%) for all blood fractions tested, but detection levels were not statistically significant and weak agreement was found between the results of the nPCR a Data are presented for a total of 297 patients for whom PBMC, plasma, serum, and whole-blood fractions were available for testing. Data in parentheses indicate percent sensitivity. Syphilis was diagnosed in patients in accordance with the CDC criteria as described in Materials and Methods. b Blood fractions were obtained as described in Materials and Methods. c Patient without syphilis as described in Table 1 . d Blood was collected from healthy volunteers with no clinical signs of syphilis and negative serological results. e For PBMC, Se was 29%, Sp was 96%, Youden's index was 0.25, PPV was 94.7%, NPV was 35%, LR ϩ was 2.3, and LR Ϫ was 0.89. f For plasma, Se was 18%, Sp was 92%, Youden's index was 0.11, PPV was 88%, NPV was 25.8%, LR ϩ was 7.2, and LR Ϫ was 0.74. g For serum, Se was 15%, Sp was 93%, Youden's index was 0.08, PPV was 88.5%, NPV was 24%, LR ϩ was 2.2, and LR Ϫ was 0.91. h For whole blood, Se was 24%, Sp was 97%, Youden's index was 0.21, PPV was 97.4%, NPV was 23%, LR ϩ was 8.9, and LR Ϫ was 0.78.
assay and syphilis diagnosis for the PBMC and whole-blood fractions. No agreement was found between the syphilis diagnosis and the detection of T. pallidum in the plasma and serum fractions. In cases of primary syphilis, the frequency of T. pallidum detection in the PBMC fraction (32%) appeared to be significantly higher than that in the plasma (12%; P ϭ 0.013) and whole-blood (13%; P ϭ 0.007) fractions. In cases of secondary syphilis, T. pallidum detection rates were highest for the whole-blood fraction (38%) and were significantly different from those for the serum fraction (15%; P ϭ 0.033) only. Overall, T. pallidum detection rates were significantly higher in patients with secondary syphilis than in patients with primary syphilis for both whole-blood (P ϭ 0.002) and plasma (P ϭ 0.018) samples. Detection rates also were higher in patients with secondary syphilis than in those with latent disease for the whole-blood fraction only (P ϭ 0.029), which is consistent with the spread of spirochetes in the blood at this stage (Table 3) . Evaluation of the effect of HIV status on the detection of T. pallidum in swabs and blood by nPCR. The sensitivity and specificity of T. pallidum DNA detection from swabs were high for HIV-negative patients (83 and 96%, respectively) but lower (76.4 and 93.3%, respectively) for HIV-positive patients. However, these differences were not significant for the detection of T. pallidum DNA (Table 4) . No statistical differences were found for the detection of T. pallidum DNA in blood fractions.
DISCUSSION
Syphilis is a major sexually transmitted disease worldwide, and accurate diagnosis is essential for efficient treatment. Some cases are difficult to diagnose, particularly if there are no clinical or atypical manifestations. During the last 15 years, several laboratories have investigated PCR methods for detecting the T. pallidum genome in samples from various origins with different levels of success (17, 18, 23, 24, 31, 32, 39) . In this study, we investigated the potential of nPCR for detecting the T. pallidum genome in swab and blood samples from a large number of patients with primary, secondary, and latent syphilis. We also included a population of patients that did not have syphilis, some with HSV-related ulceration and others with specific ulcerations unrelated to syphilis. We also included patients with ulcerations of unknown origin, as previously described (19, 20) .
We compared detection rates between the nPCR method and DFM observation, one of the principal methods used in syphilis diagnosis. Spirochete detection by DFM had a sensitivity of 72% in this study, which is consistent with previous reports (10) . The slight discrepancy between our findings and those of previous studies may be accounted for by the low treponemal load of older lesions. The retention of patients with uncertain DFM results in the study decreased the specificity to 88% due to the possible presence of nontreponemal spirochetes in mucosal samples from oral sites. Indeed, T. denticola, a spirochete found predominantly in the oral cavity, is one of 60 treponemal species found in dental plaque (33) . The five samples giving dubious DFM results (2 genital, 2 anal, and 1 cutaneous sample) contained nonmotile bacteria. All of the lesions were suggestive of syphilis, leading to the incorrect identification of a commensal spirochete as T. pallidum. These lesions were present at perianal locations in MSM, a group at high risk of syphilis, and they took the form of a diffuse cutaneous eruption. Serological test results remained negative throughout follow-up in these five patients. Fair concordance between DFM and nPCR methods was observed, at 77%, with a kappa value of 0.53. This result is consistent with previous reports of a kappa value of 0.601 for agreement between the two tests (19) . The nPCR method could be used in addition to or as a replacement for DFM under conditions in which this method cannot be used.
Analyses of swab specimens from patients diagnosed with syphilis and from patients without syphilis had good sensitivity (82%) and specificity (95%) for the detection of the T. pallidum genome in patients with primary and secondary syphilis, with a concordance of 82.6% between the nPCR method and the physician's diagnosis. These findings are consistent with those of previous studies reporting a sensitivity of 80.39% and a specificity of 98.4%, which were based on positive PCR results for 55 patients (26) . Moreover, for a total population of 68 patients, a detection sensitivity of 75% has been reported for swab samples from patients with primary syphilis (29) . In a recent study of 716 individuals, including 114 patients diagnosed with primary syphilis, the sensitivity was 72.8% and the specificity was 95.5% (17) . However, we obtained discrepant results for two patients who gave positive results by nPCR but were found not to have syphilis. Both of these patients were at high risk of syphilis, as both were MSM presenting genital ulcerations of unknown origin that could have been primary syphilis with negative serological and DFM results, which is consistent with the presence of T. pallidum, as previously shown (20) . It remains possible that these patients had early syphilis with lesions in which T. pallidum was detected only by the nPCR method, as described by Cummings et al., who used a specific antibody-based method to detect T. pallidum in the lesions of patients with early syphilis (10) . Conversely, 5 of the 19 specimens from patients diagnosed with syphilis that tested negative by nPCR were of nongenital origin (anal, buccal, and cutaneous), and the origin of a further 5 specimens was not specified. Only nine specimens were genital. These results suggest that the site used for swab sampling plays an important role in determining the T. pallidum is a highly invasive organism that is able to penetrate endothelial cell monolayers and to enter the bloodstream in vivo (38) . In this study, we were able to detect the T. pallidum genome in whole blood from patients at all stages of syphilis infection, with a poor overall sensitivity of 24% and a specificity of 97%, giving a low level of concordance (39.9%) between the PCR result and the physician's diagnosis. With our nPCR conditions, the detection of T. pallidum DNA in the PBMC fraction (32%) appears to be significantly more sensitive than detection in the plasma (12%) and whole-blood (13%) fractions in cases of primary syphilis. This result is consistent with those of previous studies (24) . Our results suggest that the use of the whole-blood fraction would be more effective for the detection of T. pallidum in cases of secondary syphilis (38%), although the results for this fraction were not significantly different from those for the PBMC fraction (31%). Previous studies on rabbit models of syphilis infection reported that whole blood was the best sample for spirochete detection (36) and that T. pallidum was detected in 46% of the whole-blood samples obtained from 57 patients with secondary syphilis (9) . This difference in sensitivity may result from the use of a different target gene (tpp47 versus polA) and the conditions in which whole blood was stored, as it has been shown that the freezing of samples may affect sensitivity (9) .
We were able to detect T. pallidum in patients with primary syphilis, suggesting that this spirochete diffuses very rapidly into the bloodstream. However, several studies have reported conflicting results, with the detection or absence of detection of the T. pallidum genome in blood from patients with primary syphilis (14, 28, 29) . This discrepancy may be accounted for by differences in the timing of sampling, corresponding to periods of spirochete diffusion or nondiffusion in the blood. Our findings suggest that T. pallidum can be collected at this stage, but with low sensitivity. The worst T. pallidum detection rates were those obtained for serum, which is consistent with previous findings in a rabbit model (39) . As in previous studies (24, 28) , we were able to detect T. pallidum in the blood of patients with latent syphilis, although sensitivity was very low for all of the blood compartments tested. This stage may correspond to a period in which T. pallidum is present in low numbers in the host, and this spirochete may seed the bloodstream intermittently (29) .
In this study, we evaluated the detection of the T. pallidum genome by nPCR in mucosal and skin ulcers and in several blood compartments in a large cohort of patients. Overall, the PCR analysis of swab samples gave results that were highly concordant with syphilis diagnosis. Blood samples, regardless of the compartment used for testing, appear to be unsuitable for PCR analysis in this context.
